Health

Northeastern Professor Mansoor Amiji Revolutionizes Disease Treatment with Cutting-Edge Nanotechnology

2025-03-28

Author: John Tan

Introduction

In an era where medical innovations are essential for tackling complex health challenges, Northeastern University’s Professor Mansoor Amiji has emerged as a trailblazer in the application of nanotechnology and new delivery systems for various diseases since he joined the faculty in 1993.

Research Focus

Amiji's extensive research focuses on the use of polymers as biomaterials, leading to the creation of membranes and hydrogels—versatile materials that can absorb and hold water while retaining their structure.

Pioneering Gene Therapy

His groundbreaking work in 2000, enriched by a sabbatical at MIT’s Robert Langer Lab, propelled him into the field of gene therapy. With support from the National Institutes of Health, he developed non-viral gene delivery systems, a key breakthrough aligned with the agency’s growing emphasis on genetic medicine and nanotech.

Advancements in Cancer Therapies

In partnership with Vladimir Torchilin, a distinguished figure in pharmaceutical sciences, Amiji has harnessed nanotechnology to bolster cancer therapies. One of the most promising aspects of their collaboration is the development of a fish-oil-based nanoemulsion that acts like a Trojan horse, ensuring that a powerful anti-cancer medication reaches malignant pancreatic cells effectively.

This was particularly challenging since the drug was initially water-insoluble. The nanoemulsion is now on the brink of late-stage development as a treatment for difficult-to-treat cancers, including pancreatic, breast, ovarian, and potentially colorectal cancer—a crucial advancement for patients facing multidrug resistance.

Innovative Approaches to Infectious Diseases

Beyond oncology, Amiji’s research extends to tackling infectious diseases and neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. His collaboration with renowned ear, nose, and throat surgeon Benjamin Bleier has resulted in innovative methods to deliver medication directly to the brain through the nasal passage.

This approach has received significant industry interest, showcasing the growing demand for effective brain-targeted drug delivery systems.

Mentorship and Education

With over 150 postdoctoral researchers, doctoral candidates, master’s students, and numerous undergraduates trained in Amiji's Translational Therapeutic Delivery Lab, he emphasizes the vital role of mentorship in scientific discovery. "I love training students," he states, reflecting on the fresh energy and innovative problem-solving approaches they bring to the lab.

Conclusion

As Amiji's pioneering work continues to evolve, his commitment to collaboration with medical professionals and industry partners remains paramount. By bridging the gap between laboratory research and practical applications, he strives to ensure that pioneering solutions reach the patients who need them most—a mission that could shape the future of medical treatments globally.

Stay tuned for more on how this revolutionary research could change the face of medicine as we know it!